Product details
Catalog number BNCB2309-500
Price for BNCB2309-500
Size / count 1x 500 µL
Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be differentially upregulated in Ewing sarcoma on the basis of array-based gene expression analysis. It acts as a valuable marker for Ewing sarcoma, with a sensitivity of 93% and a specificity of 89%, and aids in the differential diagnosis of small round cell tumors.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is BNCB2309-500.
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), Biotin conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0299061270361e1011a2/msds/bncb2309-500.pdf.
Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be diff
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.
Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.